PTMA safeguards mitochondrial integrity to sustain metabolic function and antitumor activity of CD8 T cells
Science Immunology · 23.01.2026 · 11 (115)
DOI: 10.1126/sciimmunol.adz7275 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 23.01.2026. Verfasst von Keling Huang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pediatric Infection, Immunity, and Critical Care Medicine, Shanghai Children's Hospital, Shanghai Institute of Immunology, Shanghai Jiao…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Mitochondria, Thymosin, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Jiao Tong University, National Key Research and Development Program of China.
Abstract (Originalsprache)
Immune checkpoint blockade (ICB) has transformed cancer treatment, yet its efficacy is often limited by the progressive exhaustion of tumor-reactive CD8 T cells. By analyzing transcriptomes of CD8 T cells from patients treated with ICB across cancer types, we found that prothymosin alpha (PTMA) is highly expressed in progenitor exhausted T (T PEX ) cells and is associated with treatment response. PTMA expression was directly controlled by T cell factor 1 (TCF1), a central regulator of T PEX cell maintenance in the tumor microenvironment. In mice, genetic deletion of Ptma from T cells compromised CD8 T cell persistence in tumors and abolished the therapeutic effect of programmed cell death protein 1 (PD-1) blockade. PTMA preserved mitochondrial DNA integrity through interaction with mitochondrial transcription factor A (TFAM), sustaining T cell oxidative phosphorylation under metabolic stress. Our findings identify the TCF1-PTMA axis as a molecular link between mitochondrial fitness and durable T cell–mediated antitumor immunity, offering insights and potential directions for future therapeutic strategies to boost immunotherapy efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Pediatric Infection, Immunity, and Critical Care Medicine, Shanghai Children's Hospital, Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Immunology and Microbiology, State Key Laboratory of Oncogenes and Related Genes, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- School of Medicine, Xiamen University, Xiamen, Fujian, China.
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
ORCID-Profile: Keling Huang, Xiaoxue Li, Wenhua Liang, Shuyao Wu, Youqiong Ye, Junke Zheng, Weifang Wang, Qifan Zheng, Guo Fu, Song Gao, Feng Wang
Förderung
- National Natural Science Foundation of China
- Shanghai Jiao Tong University
- National Key Research and Development Program of China
- Technology Committee of Shanghai Municipality Targeted Biomedical Emergency Project
Zitieren
APA
Huang, K., Li, X., Liang, W., Wu, S., Ye, Y., Lu, Y., Zheng, J., Wang, W., Zheng, Q., Fu, G., Gao, S., & Wang, F. (2026). PTMA safeguards mitochondrial integrity to sustain metabolic function and antitumor activity of CD8 T cells. Science Immunology, 11(115). https://doi.org/10.1126/sciimmunol.adz7275
Vancouver
Huang K, Li X, Liang W, Wu S, Ye Y, Lu Y, et al. PTMA safeguards mitochondrial integrity to sustain metabolic function and antitumor activity of CD8 T cells. Science Immunology. 2026;11(115). doi:10.1126/sciimmunol.adz7275
BibTeX
@article{Huang2026,
author = {Huang, Keling and Li, Xiaoxue and Liang, Wenhua and Wu, Shuyao and Ye, Youqiong and Lu, Yan and Zheng, Junke and Wang, Weifang and Zheng, Qifan and Fu, Guo and Gao, Song and Wang, Feng},
title = {PTMA safeguards mitochondrial integrity to sustain metabolic function and antitumor activity of CD8 T cells},
journal = {Science Immunology},
year = {2026},
volume = {11},
number = {115},
doi = {10.1126/sciimmunol.adz7275}
}
EUVIMED